Michael Barbella, Managing Editor10.05.22
Medical supplies have become the latest casualty in Russia's war with Ukraine.
GlobalData estimates the Russian market for polymerase chain reaction (PCR) systems, used to test for diseases, will plummet 44% this year, going from $44.66 million in 2021 to $17.81 million by Dec. 31.
GlobalData’s report, "PCR Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," notes that 70% of Russia’s PCR systems were imported before the conflict began in late February.
PCR systems are one of the diagnostic tests used to identify and trace COVID-19, but they can also be used to analyze and amplify lethal biological agents.
“The Russian PCR systems market will take almost a decade to recover due to the ongoing Russia-Ukraine conflict, but this will be longer if the conflict and sanctions continue," said Selena Yu, a medical devices analyst at GlobalData. "The current sanctions do not allow PCR systems to be imported, despite having crucial functions such as in-vitro diagnostics testing, as these technologies can be used to analyse and amplify lethal biological agents that may be used in military efforts. Although molecular biology systems may be considered humanitarian equipment, governments are hesitant in allowing Russia to obtain more devices that may aid in the Russian military.”
As a result, the Russian healthcare system is relying on its current PCR stockpiles and may need to request equipment from research labs throughout the country.
GlobalData estimates the Russian market for polymerase chain reaction (PCR) systems, used to test for diseases, will plummet 44% this year, going from $44.66 million in 2021 to $17.81 million by Dec. 31.
GlobalData’s report, "PCR Systems Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030," notes that 70% of Russia’s PCR systems were imported before the conflict began in late February.
PCR systems are one of the diagnostic tests used to identify and trace COVID-19, but they can also be used to analyze and amplify lethal biological agents.
“The Russian PCR systems market will take almost a decade to recover due to the ongoing Russia-Ukraine conflict, but this will be longer if the conflict and sanctions continue," said Selena Yu, a medical devices analyst at GlobalData. "The current sanctions do not allow PCR systems to be imported, despite having crucial functions such as in-vitro diagnostics testing, as these technologies can be used to analyse and amplify lethal biological agents that may be used in military efforts. Although molecular biology systems may be considered humanitarian equipment, governments are hesitant in allowing Russia to obtain more devices that may aid in the Russian military.”
As a result, the Russian healthcare system is relying on its current PCR stockpiles and may need to request equipment from research labs throughout the country.